Cancer is one of the foremost health problems worldwide and is among the leading causes
of death in the United States. Gastrointestinal tract cancers account for almost one third of …

Over the last decades, the treatment of resectable esophageal cancer has evolved into a
multidisciplinary process in which all players are essential for treatment to be successful …

Introduction Up to 32% of patients with esophageal cancer show a pathological complete
response (ypCR) after neoadjuvant therapy. To prevent overtreatment, the indication to …

Approximately half of the patients diagnosed with oesophageal cancer present with
unresectable or metastatic disease. Treatment for these patients aims to control dysphagia …

Esophageal cancer is characterized by early and frequent metastasis. Surgery is the primary
treatment for early-stage disease, whereas patients with patients with locally advanced …

Background Nearly one third of patients undergoing neoadjuvant chemoradiotherapy
(nCRT) for locally advanced esophageal cancer have a pathologic complete response …

Background Although CT, endoscopic US, and PET are critical in determining the
appropriate management of esophageal carcinoma (squamous cell carcinoma and …

Purpose Accurate preoperative prediction of pathologic response to neoadjuvant
chemoradiotherapy (nCRT) in patients with esophageal cancer could enable omission of …

Purpose To explore the potential benefit and complementary value of a multiparametric
approach using diffusion-weighted (DW-) and dynamic contrast-enhanced (DCE-) magnetic …

Objectives: To investigate the residual pattern of esophageal cancer in the esophageal wall
after neoadjuvant chemotherapy (NAC) and its clinical significance. Background: NAC is a …